Showing results (1-10 of 239) with videos related to
Sort By:
Pageof 24
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 4, 2017
Non-canonical Activation of Receptor Tyrosine Kinases in Cancer ProgressionHiroaki SakuraiTrends in Pharmacological Sciences|July 17, 2012
Targeting of TAK1 in inflammatory disorders and cancerHiroaki SakuraiBiological & Pharmaceutical Bulletin|October 3, 2017
Emerging and Diverse Functions of the EphA2 Noncanonical Pathway in Cancer ProgressionYue Zhou, Hiroaki SakuraiJournal of Proteomics|January 30, 2022
New trend in ligand-induced EGFR trafficking: A dual-mode clathrin-mediated endocytosis modelYue Zhou, Hiroaki SakuraiFASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 28, 2005
IKKbeta phosphorylates p65 at S468 in transactivaton domain 2Robert F Schwabe, Hiroaki SakuraiJournal of Physical Therapy Science|May 2, 2015
Difficulty levels of OSCE items related to examination and measurement skillsYoshikiyo Kanada, Hiroaki Sakurai, Yoshito SugiuraJournal of Physical Therapy Science|September 10, 2014
Effects of Intervention with To-balance Exercise on the Elderly Requiring Assistance and Lower Levels of CareYoshikiyo Kanada, Hiroaki Sakurai, Yoshito SugiuraMolecular Cancer Therapeutics|June 19, 2003
ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, shows antimetastatic activity using a hepatocellular carcinoma modelMitsuhiro Matsuo, Hiroaki Sakurai, Ikuo SaikiOncology Letters|April 30, 2017
Ethanolic extract of <i>Thevetia peruviana</i> flowers enhances TNF-α and TRAIL-induced apoptosis of human cervical cancer cells via intrinsic and extrinsic pathwaysChittima Managit, Hiroaki Sakurai, Ikuo SaikiBiological & Pharmaceutical Bulletin|May 1, 2024
New Directions for Advanced Targeting Strategies of EGFR Signaling in CancerYue Zhou, Jun-Ichiro Takahashi, Hiroaki SakuraiPageof 24